Transcriptional regulation of enteroendocrine cell differentiation by NeuroD

NeuroD 对肠内分泌细胞分化的转录调控

基本信息

项目摘要

DESCRIPTION (provided by applicant): The mammalian intestine continuously renews itself as intestinal stem cells give rise to four epithelial cell types. Enteroendocrine cells represent less than 5% of the total number of epithelial cells but secrete hormones that control numerous physiological processes including appetite and satiety, insulin secretion, and digestive organ function. The transcription factor, Neurogenin 3, initiates the endocrine differentiation program in the intestine and activates expression of NeuroD, another basic helix loop helix protein. NeuroD appears to coordinate terminal differentiation of enteroendocrine cells with cell cycle exit. Activation of constitutive Wnt signaling in neurogenin 3 expressing cells induced intestinal neuroendocrine tumors whereas Wnt activation in NeuroD expressing cells did not, suggesting that NeuroD expression represents a distinct, later stage of differentiation of enteroendocrine cells. The mechanism of transcriptional activation by NeuroD is not well characterized but preliminary results indicate interactions with other DNA binding proteins, CtBP, and the histone modifying enzyme, lysine specific demethylase 1 (LSD1) are involved. The paucity of identified NeuroD targets in enteroendocrine cells, has made it difficult to understand the role of this important transcription factor in their differentiation. The three aims of this proposal will address the function of NeuroD in differentiating enteroendocrine cells. Aim 1 will examine how NeuroD associates with Sp1, RREB1, and LSD1 at one its known targets, the secretin gene to form a multiprotein coactivator complex. The paradoxical coactivator function of C-terminal binding protein, CtBP, which is generally a corepressor, will be characterized by examining histone modifications and proteins CtBP and NeuroD associate with at the secretin gene enhancer. The goal of Aim 2 will study the transcriptional mechanism of inhibition of Wnt signaling by NeuroD by determining the DNA binding proteins and coactivators/corepressor complexes that NeuroD associates with at promoters regulated by Wnt/?-catenin in vitro. The role of NeuroD in the inhibition of Wnt signaling in vivo will be examined in transgenic mice that either conditionally express NeuroD or a NeuroD knockdown shRNA to determine whether expression of NeuroD at an earlier stage of differentiation prevents development of neuroendocrine tumors following Wnt activation or whether knocking down NeuroD expression removes the block to developing tumors following Wnt activation in NeuroD+ cells. Aim 3 will identify NeuroD regulated genes in normal enteroendocrine cells by gene expression profiling by high throughput sequencing (RNAseq) of RNA from NeuroD+ cells isolated from mouse small intestine by a new method developed by the principal investigator. Genome-wide chromatin occupancy studies (ChIPseq) will identify a subset of differentially expressed genes as potential direct targets by NeuroD.
描述(由申请人提供):随着肠道干细胞产生四种上皮细胞类型,哺乳动物肠道不断自我更新。肠内分泌细胞占上皮细胞总数的不到 5%,但会分泌控制许多生理过程的激素,包括食欲和饱腹感、胰岛素分泌和消化器官功能。转录因子 Neurogenin 3 启动肠道内的内分泌分化程序并激活 NeuroD(另一种基本螺旋环螺旋蛋白)的表达。 NeuroD 似乎可以协调肠内分泌细胞的终末分化和细胞周期退出。神经原素 3 表达细胞中组成型 Wnt 信号的激活诱导肠神经内分泌肿瘤,而 NeuroD 表达细胞中 Wnt 的激活则不然,这表明 NeuroD 表达代表了肠内分泌细胞分化的一个独特的后期阶段。 NeuroD 转录激活的机制尚未得到很好的表征,但初步结果表明与其他 DNA 结合蛋白 CtBP 和组蛋白修饰酶赖氨酸特异性脱甲基酶 1 (LSD1) 的相互作用也参与其中。由于肠内分泌细胞中缺乏确定的 NeuroD 靶标,因此很难理解这一重要转录因子在其分化中的作用。该提案的三个目标将解决 NeuroD 在分化肠内分泌细胞中的功能。目标 1 将研究 NeuroD 如何与 Sp1、RREB1 和 LSD1 在其已知靶标(促胰液素基因)上结合,形成多蛋白共激活复合物。 C 端结合蛋白 CtBP(通常是辅阻遏物)的矛盾共激活子功能将通过检查组蛋白修饰以及与促胰液素基因增强子相关的蛋白 CtBP 和 NeuroD 来表征。目标 2 的目标是通过确定 NeuroD 在体外与受 Wnt/β-catenin 调节的启动子相关的 DNA 结合蛋白和共激活子/辅阻遏物复合物来研究 NeuroD 抑制 Wnt 信号传导的转录机制。将在条件性表达 NeuroD 或 NeuroD 敲低 shRNA 的转基因小鼠中检查 NeuroD 在体内抑制 Wnt 信号传导中的作用,以确定 NeuroD 在分化早期的表达是否可以阻止 Wnt 激活后神经内分泌肿瘤的发展,或者敲低 NeuroD 表达是否可以消除 NeuroD+ 细胞中 Wnt 激活后肿瘤发展的阻碍。目标 3 将通过主要研究者开发的新方法对从小鼠小肠分离的 NeuroD+ 细胞的 RNA 进行高通量测序 (RNAseq) 进行基因表达谱分析,从而鉴定正常肠内分泌细胞中的 NeuroD 调节基因。全基因组染色质占用研究 (ChIPseq) 将确定差异表达基因的子集作为 NeuroD 的潜在直接目标。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Oligomeric form of C-terminal-binding protein coactivates NeuroD1-mediated transcription.
C 端结合蛋白的寡聚形式共激活 NeuroD1 介导的转录。
  • DOI:
    10.1002/1873-3468.12501
  • 发表时间:
    2017
  • 期刊:
  • 影响因子:
    3.5
  • 作者:
    Ray,SubirK;Li,HuiJ;Leiter,AndrewB
  • 通讯作者:
    Leiter,AndrewB
Distinct cellular origins for serotonin-expressing and enterochromaffin-like cells in the gastric corpus.
胃体中表达血清素和肠嗜铬样细胞的不同细胞起源。
  • DOI:
    10.1053/j.gastro.2013.11.048
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    29.4
  • 作者:
    Li,HuiJoyce;Johnston,Brian;Aiello,Daniel;Caffrey,DanielR;Giel-Moloney,Maryann;Rindi,Guido;Leiter,AndrewB
  • 通讯作者:
    Leiter,AndrewB
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANDREW B. LEITER其他文献

ANDREW B. LEITER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANDREW B. LEITER', 18)}}的其他基金

Transcriptional events controlling enteroendocrine cell differentiation
控制肠内分泌细胞分化的转录事件
  • 批准号:
    9765303
  • 财政年份:
    2016
  • 资助金额:
    $ 37.47万
  • 项目类别:
Transcriptional events controlling enteroendocrine cell differentiation
控制肠内分泌细胞分化的转录事件
  • 批准号:
    9160624
  • 财政年份:
    2016
  • 资助金额:
    $ 37.47万
  • 项目类别:
Transcriptional events controlling enteroendocrine cell differentiation
控制肠内分泌细胞分化的转录事件
  • 批准号:
    9315814
  • 财政年份:
    2016
  • 资助金额:
    $ 37.47万
  • 项目类别:
Regulation of enteroendocrine cell differentiation by Neurogenin 3 gene dosage
Neurogenin 3 基因剂量对肠内分泌细胞分化的调节
  • 批准号:
    9064762
  • 财政年份:
    2014
  • 资助金额:
    $ 37.47万
  • 项目类别:
Regulation of enteroendocrine cell differentiation by Neurogenin 3 gene dosage
Neurogenin 3 基因剂量对肠内分泌细胞分化的调节
  • 批准号:
    8848376
  • 财政年份:
    2014
  • 资助金额:
    $ 37.47万
  • 项目类别:
Regulation of enteroendocrine cell differentiation by Neurogenin 3 gene dosage
Neurogenin 3 基因剂量对肠内分泌细胞分化的调节
  • 批准号:
    8728512
  • 财政年份:
    2014
  • 资助金额:
    $ 37.47万
  • 项目类别:
Transcriptional regulation of enteroendocrine cell differentiation by NeuroD
NeuroD 对肠内分泌细胞分化的转录调控
  • 批准号:
    8017568
  • 财政年份:
    2010
  • 资助金额:
    $ 37.47万
  • 项目类别:
Transcriptional regulation of enteroendocrine cell differentiation by NeuroD
NeuroD 对肠内分泌细胞分化的转录调控
  • 批准号:
    8098191
  • 财政年份:
    2010
  • 资助金额:
    $ 37.47万
  • 项目类别:
Transcriptional regulation of enteroendocrine cell differentiation by NeuroD
NeuroD 对肠内分泌细胞分化的转录调控
  • 批准号:
    8281566
  • 财政年份:
    2010
  • 资助金额:
    $ 37.47万
  • 项目类别:
CORE--GENE EXPRESSION AND GENOMICS
核心——基因表达和基因组学
  • 批准号:
    7335644
  • 财政年份:
    2006
  • 资助金额:
    $ 37.47万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 37.47万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 37.47万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.47万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.47万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 37.47万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.47万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 37.47万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 37.47万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 37.47万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.47万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了